Interestingly, although perhaps not unexpected, this analysis also identified that hematological malignancies including lymphomas generally expressed higher levels of CD80 when compared to cell lines originating from solid epithelial cancers (Figure 4A). This evidence concerns the gene CD80 and lymphoma.